Ovid Therapeutics (OVID) Stock Highlights

3.06 | +0%

2024-06-03 03:32:31

Ovid Therapeutics Inc is a biopharmaceutical company. The firm is primarily engaged in developing impactful medicines for patients and families living who are suffering from epilepsies, seizure-related disorders, and neurological disorders. It is targeting disorders such as intellectual disability, severe speech impairment, problems with movement and balance, sleep disorders and anxiety to transform the patients life.

Statistics

Range Today

3.02 3.12

Volume Today 78.6K

Range 1 Year

2.57 4.14

Volume 1 Year 50.11M

Range 3 Year

1.4 4.8

Volume 3 Year 155.34M

Range 10 Year

1.4 15.929

Volume 10 Year 893.91M

Highlights

Market Capitalization 217.09M (small)

Floating Shares 40.75M

Current Price 3.06

Price To Earnings -4.29

Price To Revenue 300.89

Price To Book 2.77

Earnings Per Share -0.72

Payout Ratio 0%

Performance

Latest 0%

1 Month +0.33%

3 Months -9.73%

6 Months +4.44%

1 Year -11.3%

3 Years -27.14%

5 Years +93.67%

10 Years -78.14%

Benchmarks

Market Capitalization

212 / 368

Gross Profits

122 / 278

Total Revenue

265 / 300

Total Rank

344 / 368

Free Cashflow

156 / 352

Performance 5 years

63 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.